These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14679045)

  • 1. Insulin autoimmunity: immunogenetics/immunopathogenesis of type 1A diabetes.
    Eisenbarth GS
    Ann N Y Acad Sci; 2003 Nov; 1005():109-18. PubMed ID: 14679045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 1 diabetes: chronic progressive autoimmune disease.
    Zhang L; Gianani R; Nakayama M; Liu E; Kobayashi M; Baschal E; Yu L; Babu S; Dawson A; Johnson K; Jahromi M; Aly T; Fain P; Barker J; Rewers M; Eisenbarth GS
    Novartis Found Symp; 2008; 292():85-94; discussion 94-8, 122-9, 202-3. PubMed ID: 19203094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-specific tolerance in diabetes.
    Gottlieb PA; Eisenbarth GS
    Clin Immunol; 2002 Jan; 102(1):2-11. PubMed ID: 11781061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes.
    Eisenbarth GS; Moriyama H; Robles DT; Liu E; Yu L; Babu S; Redondo MJ; Gottlieb P; Wegmann D; Rewers M
    Autoimmun Rev; 2002 May; 1(3):139-45. PubMed ID: 12849007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity.
    Nakayama M; Beilke JN; Jasinski JM; Kobayashi M; Miao D; Li M; Coulombe MG; Liu E; Elliott JF; Gill RG; Eisenbarth GS
    J Clin Invest; 2007 Jul; 117(7):1835-43. PubMed ID: 17607359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stages of type 1A diabetes: 2005.
    Gianani R; Eisenbarth GS
    Immunol Rev; 2005 Apr; 204():232-49. PubMed ID: 15790362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin as an autoantigen in NOD/human diabetes.
    Zhang L; Nakayama M; Eisenbarth GS
    Curr Opin Immunol; 2008 Feb; 20(1):111-8. PubMed ID: 18178393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of autoantibodies in type 1 diabetes.
    Miao D; Yu L; Eisenbarth GS
    Front Biosci; 2007 Jan; 12():1889-98. PubMed ID: 17127428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes.
    Azam A; Eisenbarth GS
    Expert Opin Biol Ther; 2004 Oct; 4(10):1569-75. PubMed ID: 15461568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?
    O'Kell AL; Wasserfall C; Catchpole B; Davison LJ; Hess RS; Kushner JA; Atkinson MA
    Diabetes; 2017 Jun; 66(6):1443-1452. PubMed ID: 28533295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of type 1A diabetes.
    Eisenbarth GS; Jeffrey J
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):146-55. PubMed ID: 18438525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.
    Nakayama M; Abiru N; Moriyama H; Babaya N; Liu E; Miao D; Yu L; Wegmann DR; Hutton JC; Elliott JF; Eisenbarth GS
    Nature; 2005 May; 435(7039):220-3. PubMed ID: 15889095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin as a primary autoantigen for type 1A diabetes.
    Jasinski JM; Eisenbarth GS
    Clin Dev Immunol; 2005 Sep; 12(3):181-6. PubMed ID: 16295523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice.
    Robles DT; Eisenbarth GS; Dailey NJ; Peterson LB; Wicker LS
    Diabetes; 2003 Mar; 52(3):882-6. PubMed ID: 12606534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of islet antigen presenting cells and the presentation of insulin in the initiation of autoimmune diabetes in the NOD mouse.
    Unanue ER; Ferris ST; Carrero JA
    Immunol Rev; 2016 Jul; 272(1):183-201. PubMed ID: 27319351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes.
    Devendra D; Paronen J; Moriyama H; Miao D; Eisenbarth GS; Liu E
    J Autoimmun; 2004 Aug; 23(1):17-26. PubMed ID: 15236749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.
    Brezar V; Carel JC; Boitard C; Mallone R
    Endocr Rev; 2011 Oct; 32(5):623-69. PubMed ID: 21700723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune mechanisms leading to type 1 insulin-dependent diabetes mellitus.
    Boitard C; Timsit J; Larger E; Dubois D
    Horm Res; 1997; 48 Suppl 4():58-63. PubMed ID: 9350450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal islet sphingolipid metabolism in type 1 diabetes.
    Holm LJ; Krogvold L; Hasselby JP; Kaur S; Claessens LA; Russell MA; Mathews CE; Hanssen KF; Morgan NG; Koeleman BPC; Roep BO; Gerling IC; Pociot F; Dahl-Jørgensen K; Buschard K
    Diabetologia; 2018 Jul; 61(7):1650-1661. PubMed ID: 29671030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
    Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
    Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.